DexCom’s shares shot up as much as 8% in the trading session following the announcement. The stock has been up 2.6% since the news release. Currently, the DexCom G4 PLATINUM (Pediatric) is the only ...
The US Food and Drug Administration (FDA) has approved a new insulin pump/continuous glucose monitor (CGM) product, Tandem's t:slim Insulin Pump and Dexcom G4 PLATINUM CGM System, according to a ...
SAN DIEGO, Jan. 8, 2013 /PRNewswire/ -- Tandem Diabetes Care, Inc. ("Tandem") announced today that its Development and Commercialization Agreement with Dexcom, Inc., has been expanded to include ...
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. A warning letter posted Tuesday by the Food and Drug ...
Dexcom has received approval from the FDA for a new version of its smartphone connected Dexcom Share platform that will eliminate the docking cradle and allow a patient's continuous glucose monitor ...
A new study of Dexcom's G4 Platinum continuous glucose monitor showed that more than half of the participants experienced a 10% or higher reduction in an important indicator for developing ...
Dexcom announced today that it’s preparing updates to its two mobile apps that will allow users of its Continuous Glucose Monitor System to track everything straight from Apple Watch. The apps will ...
Dexcom ($DXCM) won FDA approval for its next-generation mobile communications device for diabetes monitoring, chalking up another regulatory win and furthering the ...
DexCom’s shares shot up as much as 8% in the trading session following the announcement. The stock has been up 2.6% since the news release. Currently, the DexCom G4 PLATINUM (Pediatric) is the only ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results